Clinical Trial

18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis

Name: 18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis — clinical trial record (NCT06937112)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Record status

This record was last updated April 22, 2025 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.

Summary

Evaluate the safety of the novel FAP targeted molecular probe 18F-FAPI-YQ104 labeled with radioactive isotopes in clinical applications and verify its effectiveness in tumor diagnosis.

Trial Details

NCT Number	NCT06937112
Lead Sponsor	Nanjing First Hospital, Nanjing Medical University
Conditions	Lung Cancers, Pancreatic Cancer, Neuroendocrine Tumors, Thyroid Cancer
Enrollment	20 participants
Start Date	2025-04-10
Primary Completion	2026-01-31 (estimated)
Study Completion	2026-03-31 (estimated)
Updated on ClinicalTrials.gov	2025-04-22